For the third week of CRAWDAQ, we're taking a trip to Vermilion Parish, where a crawfish supplier, a specialist and major players in the history of the crawfish restaurant industry are sharing.
The initial application of the company’s RNA platform is against White Spot Virus (WSSV), which causes an annual loss of around $3bn and a 15% reduction in global shrimp production.
/PRNewswire/ ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health.